Recurrent Breast Cancer Withdrawn Phase 2 Trials for Methotrexate (DB00563)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003536Methotrexate With or Without Antineoplaston Therapy in Treating Postmenopausal Women With Advanced Refractory Breast CancerTreatment